Godavari Drugs Ltd

NSE: BSE: 530317

₹81.77

(-1.35%)

Wed, 18 Mar 2026, 01:57 pm

MTF 5xInvest in Godavari Drugs Ltd with 5x Leverage Buy with MTF

Market Cap624.2M

PE Ratio16.68

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Godavari Drugs Financials

Income Statement Balance Sheet Cashflow

Particulars	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total revenue	25.86M	39.60M	39.47M	37.28M	43.60M	52.37M	37.17M	76.24M	93.21M	548.46M	711.21M	755.99M	644.48M	835.44M	956.98M	1.23B	1.61B	1.60B	1.57B	1.13B
Gross profit	-24.36M	932.05K	-5.52M	283.54K	3.57M	6.91M	-8.29M	20.93M	19.49M	66.08M	59.62M	70.58M	64.48M	83.97M	85.68M	139.38M	156.19M	160.64M	182.11M	149.58M
Operating expenses (excl. COGS)	269.40K	-10.31M	-759.76K	-2.52M	-4.51M	-6.36M	-6.54M	-15.28M	-11.54M	-15.07M	-20.71M	-26.10M	-33.93M	-40.06M	-36.95M	-53.34M	-59.61M	-58.20M	-66.25M	-51.45M
Selling/general/admin expenses, total	—	—	—	—	-4.29M	-6.17M	-6.39M	-15.10M	-11.30M	-14.44M	-20.05M	-25.26M	-33.49M	-38.78M	-36.39M	-52.05M	-58.36M	-59.72M	-65.89M	-50.48M
Research & development	-371.81K	-399.25K	-846.02K	-1.07M	-1.29M	-2.12M	-1.49M	-1.41M	-1.54M	-2.30M	-2.51M	-2.60M	-3.08M	-3.12M	-2.48M	-2.65M	-2.88M	-2.82M	-3.25M	-2.34M
Selling/general/admin expenses, other	—	—	—	—	-2.99M	-4.05M	-4.90M	-13.70M	-9.76M	-12.14M	-17.53M	-22.67M	-30.42M	-35.66M	-33.90M	-49.40M	-55.48M	-56.90M	-62.64M	-48.14M
Other operating expenses, total	269.40K	-10.31M	-759.76K	-2.52M	-223.51K	-189.34K	-152.81K	-178.93K	-239.10K	-629.03K	-661.85K	-835.69K	-436.66K	-1.28M	-564.70K	-1.29M	-1.25M	1.52M	-363.00K	-965.00K
Operating income	-24.46M	-9.38M	-7.13M	-2.23M	-942.21K	554.02K	-14.83M	5.65M	7.95M	51.00M	38.91M	44.48M	30.55M	43.91M	48.73M	86.04M	96.58M	102.44M	115.86M	98.13M
Non-operating income, total	64.13M	18.46M	-694.04K	-207.84K	-870.80K	-261.67K	-1.14M	1.54M	-921.92K	-3.67M	-17.13M	-17.40M	-17.41M	-26.45M	-25.84M	-28.98M	-26.38M	-53.09M	-46.64M	-41.88M
Interest expense, net of interest capitalized	-3.72M	-1.38M	-2.02M	-1.52M	-1.20M	-1.09M	-1.44M	-2.07M	-2.09M	-6.68M	-18.80M	-25.09M	-24.18M	-28.90M	-29.11M	-33.08M	-28.49M	-39.27M	-49.15M	-47.32M
Interest capitalized	0	0	0	—	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non-operating income, excl. interest expenses	3.07M	3.88M	1.33M	1.32M	331.70K	832.01K	301.25K	3.61M	1.16M	3.01M	1.89M	8.02M	6.77M	2.45M	3.28M	4.10M	2.11M	-13.82M	2.51M	5.44M
Non-operating interest income	481.25K	1.12M	95.15K	99.15K	95.14K	95.15K	101.71K	210.45K	176.79K	170.38K	530.32K	504.44K	845.79K	884.17K	692.31K	802.54K	1.10M	1.28M	1.07M	1.06M
Miscellaneous non-operating expense	2.59M	2.76M	1.23M	1.22M	236.56K	736.86K	199.54K	3.40M	986.78K	2.84M	1.36M	7.52M	5.92M	1.56M	2.58M	3.30M	1.01M	-15.11M	1.44M	4.38M
Unusual income/expense	64.78M	15.96M	—	—	—	—	—	—	—	—	-219.43K	-330.79K	—	0	0	0	0	0	0	0
Pretax income	39.67M	9.09M	-7.82M	-2.44M	-1.81M	292.34K	-15.97M	7.19M	7.03M	47.34M	21.78M	27.08M	13.14M	17.46M	22.89M	57.06M	70.21M	49.35M	69.22M	56.25M
Taxes	-6.59M	1.37M	-20.23K	-224.45K	-105.00K	-12.00K	0	-2.37M	8.49M	-10.87M	-8.27M	-8.99M	-4.85M	-5.37M	-2.88M	-15.78M	-17.75M	-11.49M	-13.73M	-12.45M
Non-controlling/minority interest	0	0	0	—	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
After tax other income/expense	0	0	0	—	-63.44K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net income before discontinued operations	33.08M	10.46M	-7.84M	-2.67M	-1.98M	280.34K	-15.97M	4.82M	15.52M	36.47M	13.51M	18.09M	8.29M	12.08M	20.01M	41.28M	52.45M	37.86M	55.49M	43.80M
Net income	33.08M	10.46M	-7.84M	-2.67M	-1.98M	280.34K	-15.97M	4.82M	15.52M	36.47M	13.51M	18.09M	8.29M	12.08M	20.01M	41.28M	52.45M	37.86M	55.49M	43.80M
Dilution adjustment	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred dividends	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Diluted net income available to common stockholders	33.08M	10.46M	-7.84M	-2.67M	-1.98M	280.34K	-15.97M	4.82M	15.52M	36.47M	13.51M	18.09M	8.29M	12.08M	20.01M	41.28M	52.45M	37.86M	55.49M	43.80M
Basic earnings per share (Basic EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted earnings per share (Diluted EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-15.36M	270.60K	2.50M	7.38M	8.68M	10.22M	-4.85M	20.62M	23.01M	60.92M	45.17M	52.55M	40.40M	54.78M	60.35M	98.27M	113.55M	121.88M	135.80M	122.61M
EBIT	-24.46M	-9.38M	-7.13M	-2.23M	-942.21K	554.02K	-14.83M	5.65M	7.95M	51.00M	38.91M	44.48M	30.55M	43.91M	48.73M	86.04M	96.58M	102.44M	115.86M	98.13M
Total operating expenses	-50.33M	-48.97M	-46.60M	-39.52M	-44.55M	-51.82M	-52.00M	-70.58M	-85.26M	-497.46M	-672.30M	-711.50M	-613.93M	-791.53M	-908.25M	-1.14B	-1.51B	-1.49B	-1.45B	-1.04B
Prepaid expenses	479.22K	720.77K	660.31K	704.95K	252.67K	1.11M	369.88K	359.24K	594.10K	716.16K	1.03M	806.68K	1.27M	3.49M	4.20M	9.06M	14.14M	—	—	—
Deferred income, current	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Capital and operating lease obligations	—	0	0	—	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating lease liabilities	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax liabilities	3.63M	2.45M	2.11M	2.12M	2.22M	2.22M	2.22M	4.60M	4.93M	7.31M	9.46M	12.04M	14.21M	6.77M	5.75M	9.65M	15.14M	16.46M	18.63M	19.18M
Deferred income, non-current	0	0	0	—	0	0	0	0	0	0	—	—	—	—	—	—	—	—	—	—
Minority interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in accrued expenses	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Common dividends paid	0	0	0	—	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred dividends paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800